Dec. 5, 2019 Price forecast | 2 weeks: -5.75% | 1 month: -11.97% | 3 months: -15.37%


IMMU stock forecast

Our latest prediction for Immunomedics, Inc.'s stock price was made on the Dec. 5, 2019 when the stock price was at 18.50$.

In the short term (2weeks), IMMU's stock price should underperform the market by -5.75%. During that period the price should oscillate between -9.81% and +9.11%.

In the medium term (3months), IMMU's stock price should underperform the market by -15.37%. During that period the price should oscillate between -34.49% and +18.49%.


About Immunomedics, Inc.

Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ.

At the moment the company generates 1M USD in revenues.

On its last earning announcement, the company reported a loss of -1.14$ per share.

The book value per share is 2.14$

Immunomedics, Inc. website


Three months stock forecastDec. 5, 2019


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
1M -643.00% -177M -817.60% -219M -1.14 - - 170M 2.14 -163M -12M -175M